Morning Overview on MSN
FDA says "manipulated" data backed approval, moves to withdraw the drug
The FDA has moved to pull Tavneos (avacopan) from the U.S. market, alleging that manipulated clinical trial data propped up ...
MedPage Today on MSN
FDA claims 'manipulated' data led to drug's approval, proposes withdrawal
Pivotal trial on avacopan was negative before actions of unblinded study personnel, agency ...
The FDA has renewed calls for Amgen’s Tavneos to be pulled from the market, saying it has discovered new evidence that study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results